{"id":158354,"date":"2023-08-10T23:58:51","date_gmt":"2023-08-10T23:58:51","guid":{"rendered":"https:\/\/tecscience.tec.mx\/en\/?p=158354"},"modified":"2024-12-09T13:37:13","modified_gmt":"2024-12-09T19:37:13","slug":"progress-on-rna-vaccines","status":"publish","type":"post","link":"https:\/\/tecscience.tec.mx\/en\/biotechnology\/progress-on-rna-vaccines\/","title":{"rendered":"Progress on RNA vaccines\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0"},"content":{"rendered":"\n

Using mRNA technology to combat Covid-19<\/a> set the stage for a new way of creating vaccines for other diseases such as Zika, dengue, influenza, and rabies. People are even talking about the possibility of finding a universal vaccine for any type of flu<\/a>.<\/p>\n\n\n\n

Traditional vaccines work by injecting weakened or inactivated versions of pathogens and the body learns to combat the bacteria or virus. However, RNA vaccines use ribonucleic acid that teaches our cells to produce a protein or a part of a protein that stimulates the immune system to spring to our defense. So, when a pathogen enters the body, it already knows how to defend itself.<\/p>\n\n\n\n

According to an article published in the journal of the Spanish Society of Infectious Diseases and Clinical Microbiology<\/a>, the advantages of this type of immunization are that RNA is a noninfectious molecule that is produced rapidly at scale and it does not use embryonic eggs or cell cultures that alter the vaccine\u2019s results.<\/p>\n\n\n\n

\u201cmRNA vaccines meet most of these requirements, having demonstrated the capacity to protect animals from different influenza strains, although these data need to be transferred to humans,\u201d concludes Jordi Reina in the article published in May.<\/p>\n\n\n\n

\n